ArticleDiabetology & metabolic syndrome2026

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes with CKD stages 2-4: a target trial emulation.

Yung-Chih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.